Xtx Topco LTD Gilead Sciences, Inc. Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 11,426 shares of GILD stock, worth $783,937. This represents 0.12% of its overall portfolio holdings.

Number of Shares

11,426

Holding current value

$783,937

% of portfolio

0.12%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $817,873 - $997,375	11,426 New	11,426 $836,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $161,558 - $176,263	-2,185 Reduced 21.31%	8,070 $604,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $779,482 - $889,108	10,255 New	10,255 $790,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $9,223 - $13,241	148 Added 3.11%	4,902 $420,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $870,177 - $993,966	-14,615 Reduced 75.46%	4,754 $293,000

Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $466,897 - $525,865	8,089 Added 71.71%	19,369 $1.2 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $339,584 - $425,536	5,863 Added 108.23%	11,280 $671,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $591,965 - $671,891	-9,124 Reduced 62.75%	5,417 $393,000
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $984,280 - $1.06 Million	14,541 New	14,541 $1.02 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

Black Rock Inc. New York, NY

123M
Shares

$8.41 Billion
0.21% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$7.87 Billion
0.17% of portfolio
Capital World Investors Los Angeles, CA

84.5M
Shares

$5.8 Billion
1.06% of portfolio
Capital Research Global Investors Los Angeles, CA

61.2M
Shares

$4.2 Billion
1.05% of portfolio
State Street Corp Boston, MA

57.7M
Shares

$3.96 Billion
0.19% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account